The Jun N-terminal kinases signaling pathway plays a “seesaw” role in ovarian carcinoma: a molecular aspect
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Jun N-terminal kinases signaling pathway plays a “seesaw” role in ovarian carcinoma: a molecular aspect
Authors
Keywords
-
Journal
Journal of Ovarian Research
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-10-21
DOI
10.1186/s13048-019-0573-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- JNK signaling in cancer cell survival
- (2019) Qinghua Wu et al. MEDICINAL RESEARCH REVIEWS
- Low glucose and metformin-induced apoptosis of human ovarian cancer cells is connected to ASK1 via mitochondrial and endoplasmic reticulum stress-associated pathways
- (2019) Liwei Ma et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Ovarian cancer statistics, 2018
- (2018) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Comprehensive Characterization of Cancer Driver Genes and Mutations
- (2018) Matthew H. Bailey et al. CELL
- Treatment and outcome of elderly patients with advanced stage ovarian cancer: A nationwide analysis
- (2018) M.S. Schuurman et al. GYNECOLOGIC ONCOLOGY
- New insights into the role and mechanism of c-Jun-N-terminal kinase signaling in the pathobiology of liver diseases
- (2018) Sanda Win et al. HEPATOLOGY
- MiR-21-mediated Metabolic Alteration of Cancer-associated Fibroblasts and Its Effect on Pancreatic Cancer Cell Behavior
- (2018) Shuo Chen et al. International Journal of Biological Sciences
- ASK1 inhibitor treatment suppresses p38/JNK signalling with reduced kidney inflammation and fibrosis in rat crescentic glomerulonephritis
- (2018) Liv A. Amos et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Cisplatin based therapy: the role of the mitogen activated protein kinase signaling pathway
- (2018) Iman W. Achkar et al. Journal of Translational Medicine
- Ormeloxifene-induced unfolded protein response contributes to autophagy-associated apoptosis via disruption of Akt/mTOR and activation of JNK
- (2018) Arindam Bhattacharjee et al. Scientific Reports
- Targeting BCL-2 regulated apoptosis in cancer
- (2018) Kirsteen J. Campbell et al. Open Biology
- Management of endometrial, ovarian and cervical cancer in the elderly: current approach to a challenging condition
- (2018) Salvatore Giovanni Vitale et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- PKP3 interactions with MAPK-JNK-ERK1/2-mTOR pathway regulates autophagy and invasion in ovarian cancer
- (2018) Vincent Lim et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Nintedanib for Advanced Epithelial Ovarian Cancer: A Change of Perspective? Summary of Evidence from a Systematic Review
- (2018) Fabio Barra et al. GYNECOLOGIC AND OBSTETRIC INVESTIGATION
- Mitogen-activated protein kinase phosphatase 1 (MKP-1) in macrophage biology and cardiovascular disease. A redox-regulated master controller of monocyte function and macrophage phenotype
- (2017) Hong Seok Kim et al. FREE RADICAL BIOLOGY AND MEDICINE
- PP6 Disruption Synergizes with Oncogenic Ras to Promote JNK-Dependent Tumor Growth and Invasion
- (2017) Xianjue Ma et al. Cell Reports
- Epidemiology of ovarian cancer: a review
- (2017) Reid Brett M. et al. Cancer Biology & Medicine
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial
- (2016) Andreas du Bois et al. LANCET ONCOLOGY
- Nilotinib reduced the viability of human ovarian cancer cells via mitochondria-dependent apoptosis, independent of JNK activation
- (2016) Tze-Chien Chen et al. TOXICOLOGY IN VITRO
- Neferine induces autophagy of human ovarian cancer cells via p38 MAPK/ JNK activation
- (2016) Limei Xu et al. TUMOR BIOLOGY
- The Fra-1–miR-134–SDS22 feedback loop amplifies ERK/JNK signaling and reduces chemosensitivity in ovarian cancer cells
- (2016) Jianmin Wu et al. Cell Death & Disease
- Role of Wnt/β-catenin, Wnt/c-Jun N-terminal kinase and Wnt/Ca2+ pathways in cisplatin-induced chemoresistance in ovarian cancer
- (2016) Lu Huang et al. Experimental and Therapeutic Medicine
- JNK Phosphorylates SIRT6 to Stimulate DNA Double-Strand Break Repair in Response to Oxidative Stress by Recruiting PARP1 to DNA Breaks
- (2016) Michael Van Meter et al. Cell Reports
- TP53 mutations in epithelial ovarian cancer
- (2016) Yu Zhang et al. Translational Cancer Research
- Senescent peritoneal mesothelium induces a pro-angiogenic phenotype in ovarian cancer cells in vitro and in a mouse xenograft model in vivo
- (2015) Justyna Mikuła-Pietrasik et al. CLINICAL & EXPERIMENTAL METASTASIS
- JNK-Bcl-2/Bcl-xL-Bax/Bak Pathway Mediates the Crosstalk between Matrine-Induced Autophagy and Apoptosis via Interplay with Beclin 1
- (2015) Jiong Yang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cambogin Induces Caspase-Independent Apoptosis through the ROS/JNK Pathway and Epigenetic Regulation in Breast Cancer Cells
- (2015) K. Shen et al. MOLECULAR CANCER THERAPEUTICS
- PPARβ/δ Agonist Provides Neuroprotection by Suppression of IRE1α–Caspase-12-Mediated Endoplasmic Reticulum Stress Pathway in the Rotenone Rat Model of Parkinson’s Disease
- (2015) Qiang Tong et al. MOLECULAR NEUROBIOLOGY
- Time-staggered inhibition of JNK effectively sensitizes chemoresistant ovarian cancer cells to cisplatin and paclitaxel
- (2015) MANABU SEINO et al. ONCOLOGY REPORTS
- Nintedanib modulates surfactant protein-D expression in A549 human lung epithelial cells via the c-Jun N-terminal kinase-activator protein-1 pathway
- (2015) Koichiro Kamio et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics
- (2015) A. N. Hata et al. Cancer Discovery
- c-Jun transcriptionally regulates alpha 1, 2-fucosyltransferase 1 (FUT1) in ovarian cancer
- (2014) Na Gao et al. BIOCHIMIE
- The MAPK pathway across different malignancies: A new perspective
- (2014) Mauricio Burotto et al. CANCER
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Overexpression of c-fos promotes cell invasion and migration via CD44 pathway in oral squamous cell carcinoma
- (2014) Cong Dong et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Cypermethrin induces astrocyte damage: Role of aberrant Ca2+, ROS, JNK, P38, matrix metalloproteinase 2 and migration related reelin protein
- (2014) Shailendra Kumar Maurya et al. PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY
- Upregulation of miR-21 in Cisplatin Resistant Ovarian Cancer via JNK-1/c-Jun Pathway
- (2014) Ileabett M. Echevarría-Vargas et al. PLoS One
- JNK interaction with Sab mediates ER stress induced inhibition of mitochondrial respiration and cell death
- (2014) S Win et al. Cell Death & Disease
- JNK confers 5-fluorouracil resistance in p53-deficient and mutant p53-expressing colon cancer cells by inducing survival autophagy
- (2014) Xinbing Sui et al. Scientific Reports
- Tumor glycolysis as a target for cancer therapy: progress and prospects
- (2013) Shanmugasundaram Ganapathy-Kanniappan et al. Molecular Cancer
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- Survival for Ovarian Cancer in Europe: The across-country variation did not shrink in the past decade
- (2012) Willi Oberaigner et al. ACTA ONCOLOGICA
- A Liver Full of JNK: Signaling in Regulation of Cell Function and Disease Pathogenesis, and Clinical Approaches
- (2012) Ekihiro Seki et al. GASTROENTEROLOGY
- Significance of age and comorbidity on treatment modality, treatment adherence, and prognosis in elderly ovarian cancer patients
- (2012) Trine Lembrecht Jørgensen et al. GYNECOLOGIC ONCOLOGY
- The critical roles of endoplasmic reticulum chaperones and unfolded protein response in tumorigenesis and anticancer therapies
- (2012) B Luo et al. ONCOGENE
- Therapeutic targets in the ASK1-dependent stress signaling pathways
- (2012) Ryoichi HAYAKAWA et al. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- JNK2 is activated during ER stress and promotes cell survival
- (2012) M Raciti et al. Cell Death & Disease
- Regulation of the Autophagic Bcl-2/Beclin 1 Interaction
- (2012) Jean-Paul Decuypere et al. Cells
- Mitochondria to nucleus translocation of AIF in mice lacking Hsp70 during ischemia/reperfusion
- (2011) Sangita Choudhury et al. BASIC RESEARCH IN CARDIOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo
- (2011) A. B. Gaur et al. NEURO-ONCOLOGY
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Macroautophagy and chaperone-mediated autophagy are required for hepatocyte resistance to oxidant stress
- (2010) Yongjun Wang et al. HEPATOLOGY
- Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
- (2010) Ahmed Ashour Ahmed et al. JOURNAL OF PATHOLOGY
- Autophagy: cellular and molecular mechanisms
- (2010) Danielle Glick et al. JOURNAL OF PATHOLOGY
- Involvement of p38 MAPK- and JNK-modulated expression of Bcl-2 and Bax in Naja nigricollis CMS-9-induced apoptosis of human leukemia K562 cells
- (2010) Ying-Jung Chen et al. TOXICON
- c-Jun-NH2-kinase-1 Inhibition Leads to Antitumor Activity in Ovarian Cancer
- (2009) P. Vivas-Mejia et al. CLINICAL CANCER RESEARCH
- JNK1-Mediated Phosphorylation of Bcl-2 Regulates Starvation-Induced Autophagy
- (2008) Yongjie Wei et al. MOLECULAR CELL
- JNK signaling in apoptosis
- (2008) D N Dhanasekaran et al. ONCOGENE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started